​

Belite Bio (BLTE) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

BLTE Stock Forecast

Belite Bio (BLTE) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $60.00, with a high of $60.00 and a low of $60.00. This represents a -36.05% decline from the last price of $93.82.

$35 $47 $59 $71 $83 $95 High: $60 Avg: $60 Low: $60 Last Closed Price: $93.82

BLTE Stock Rating

Belite Bio stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

BLTE Price Target Upside V Benchmarks

TypeNameUpside
StockBelite Bio-36.05%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$93.82$93.82$93.82
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2523---5
Sep, 2523---5
Aug, 2523---5
Jul, 2523---5
Jun, 2523---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 13, 2024Yi ChenH.C. Wainwright$60.00$48.5523.58%-36.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 26, 2025BenchmarkBuyBuyhold
Sep 12, 2024H.C. WainwrightBuyBuyhold
Aug 13, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.19-----
Avg Forecast$-1.29$-1.17$-1.01$-0.61$0.54$3.44
High Forecast$-1.25$-1.14$0.12$0.12$1.17$3.44
Low Forecast$-1.36$-1.23$-1.58$-1.59$-0.50$3.44
Surprise %-7.75%-----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$16.67M$16.67M$55.95M$106.09M$245.76M
High Forecast-$16.67M$16.67M$55.95M$106.09M$245.76M
Low Forecast-$16.67M$16.67M$55.95M$106.09M$245.76M
Surprise %------

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-31.63M-----
Avg Forecast$-34.64M$-31.55M$-31.56M$-20.11M$18.99M$91.39M
High Forecast$-33.22M$-30.39M$3.25M$3.19M$31.04M$91.39M
Low Forecast$-36.06M$-32.71M$-41.91M$-42.28M$-13.34M$91.39M
Surprise %-8.68%-----

BLTE Forecast FAQ

Is Belite Bio stock a buy?

Belite Bio stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Belite Bio is a favorable investment for most analysts.

What is Belite Bio's price target?

Belite Bio's price target, set by 4 Wall Street analysts, averages $60 over the next 12 months. The price target range spans from $60 at the low end to $60 at the high end, suggesting a potential -36.05% change from the previous closing price of $93.82.

How does Belite Bio stock forecast compare to its benchmarks?

Belite Bio's stock forecast shows a -36.05% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Belite Bio over the past three months?

  • October 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Belite Bio’s EPS forecast?

Belite Bio's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.17, marking a -1.68% decrease from the reported $-1.19 in 2023. Estimates for the following years are $-1.01 in 2025, $-0.61 in 2026, $0.54 in 2027, and $3.44 in 2028.

What is Belite Bio’s revenue forecast?

Belite Bio's average annual revenue forecast for its fiscal year ending in December 2024 is $16.67M, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $16.67M, followed by $55.95M for 2026, $106.09M for 2027, and $245.76M for 2028.

What is Belite Bio’s net income forecast?

Belite Bio's net income forecast for the fiscal year ending in December 2024 stands at $-31.554M, representing a -0.25% decrease from the reported $-31.632M in 2023. Projections indicate $-31.558M in 2025, $-20.109M in 2026, $18.99M in 2027, and $91.39M in 2028.